Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.08 USD | +0.96% | -1.22% | -30.06% |
05-24 | HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating | MT |
05-24 | Deutsche Bank Starts Legend Biotech With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.06% | 7.6B | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Barclays Starts Legend Biotech at Overweight With $53 Price Target